Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 389, doi. 10.1007/s11899-017-0400-3
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2017 AND VI 12 AND IP 5
Results: 15
1
2
Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 397, doi. 10.1007/s11899-017-0401-2
- By:
- Publication type:
- Article
3
Contemporary Use of Interferon Therapy in the Myeloproliferative Neoplasms.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 406, doi. 10.1007/s11899-017-0402-1
- By:
- Publication type:
- Article
4
Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 415, doi. 10.1007/s11899-017-0404-z
- By:
- Publication type:
- Article
5
Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 448, doi. 10.1007/s11899-017-0405-y
- By:
- Publication type:
- Article
6
Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 455, doi. 10.1007/s11899-017-0406-x
- By:
- Publication type:
- Article
7
Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 461, doi. 10.1007/s11899-017-0407-9
- By:
- Publication type:
- Article
8
Therapy for Chronic Myelomonocytic Leukemia in a New Era.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 468, doi. 10.1007/s11899-017-0408-8
- By:
- Publication type:
- Article
9
Familial MPN Predisposition.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 442, doi. 10.1007/s11899-017-0414-x
- By:
- Publication type:
- Article
10
Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based Strategies.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 484, doi. 10.1007/s11899-017-0410-1
- By:
- Publication type:
- Article
11
Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 478, doi. 10.1007/s11899-017-0412-z
- By:
- Publication type:
- Article
12
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 432, doi. 10.1007/s11899-017-0413-y
- By:
- Publication type:
- Article
13
Minimal Residual Disease Eradication in CML: Does It Really Matter?
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 495, doi. 10.1007/s11899-017-0409-7
- By:
- Publication type:
- Article
14
Approach to MPN Symptom Assessment.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 381, doi. 10.1007/s11899-017-0399-5
- By:
- Publication type:
- Article
15
Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender.
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 5, p. 424, doi. 10.1007/s11899-017-0411-0
- By:
- Publication type:
- Article